Skip to content
value.today
Handok Inc. logo

Handok Inc.

002390.KS
$151 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

Handok Inc. in brief

Handok Inc. is a listed company in the Pharmaceutical industry, based in South Korea. Its last known market value was $151 M (January 2024); there is no current figure. Its shares trade under the symbol 002390.KS (South Korea).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Market cap history

$0 M$114 M$228 M$342 M$456 M20202021202220232024

World rank over time

▼ down 4,975 places since 2020
2020-01-01: #14407#14,40720202021-01-01: #11995#11,99520212022-01-07: #17489#17,48920222022-12-25: #18496#18,49620222023-07-30: #19886#19,88620232024-01-05: #19382#19,3822024

Rank in South Korea: #324 (Jan 2020) · #277 (Jan 2021) · #400 (Jan 2022) · #545 (Dec 2022) · #682 (Jul 2023) · #661 (Jan 2024)

Mutual funds holding Handok Inc.#

5 funds hold shares worth $0 M. Since their previous reports 0 added shares and 5 sold, selling $0 M net.
Mutual funds holding Handok Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP12,708$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP7,766$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP5,594$0 M—<0.01%no changeJul 31, 2026
🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP3,747$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Markets ex China Core Equity ETFDimensional Fund Advisors LP32$0 M—<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 5 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
Handok Inc.🇰🇷$151 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Profile updated:
Nov 15, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Handok Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Handok Inc.'s ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Handok Inc.? Suggest a correction